相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
Seri Hong et al.
CANCER RESEARCH AND TREATMENT (2020)
Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study
Yeon-Hee Baek et al.
CANCER EPIDEMIOLOGY (2019)
Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States
Rohini K. Hernandez et al.
BMC CANCER (2018)
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma
James J. Harding et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Skeletal-related events and overall survival of patients with bone metastasis from nonsmall cell lung cancer - A retrospective analysis
Pengyu Kong et al.
MEDICINE (2017)
Survival after bone metastasis by primary cancer type: a Danish population-based cohort study
Elisabeth Svensson et al.
BMJ OPEN (2017)
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
Roger von Moos et al.
SUPPORTIVE CARE IN CANCER (2016)
A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
Seil Sohn et al.
SPINE JOURNAL (2016)
Bone metastases in gastrointestinal cancer
Fabienne Portales et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Bone health in cancer patients: ESMO Clinical Practice Guidelines
R. Coleman et al.
ANNALS OF ONCOLOGY (2014)
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey
Nicola Silvestris et al.
PLOS ONE (2013)
Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems
Gerry Oster et al.
SUPPORTIVE CARE IN CANCER (2013)
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study
D. Santini et al.
ANNALS OF ONCOLOGY (2012)
Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark
Annette O. Jensen et al.
BMC CANCER (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007)
Mette Norgaard et al.
JOURNAL OF UROLOGY (2010)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases - Analysis of a national medical claims database
Hind T. Hatoum et al.
CANCER (2008)
Economic burden of metastatic bone disease in the US
Kathy L. Schulman et al.
CANCER (2007)
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors - A randomized, phase III, double-blind, placebo-controlled trial
LS Rosen et al.
CANCER (2004)
Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion
LS Rosen et al.
CANCER (2004)
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
F Saad et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cancer and other solid tumors study group
LS Rosen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
F Saad et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
分享论文
